Sleep behavior and daily activity levels in people with metabolic syndrome: effect of 1 year of metformin treatment

Impaired sleep and low daily activity levels increase the risk of developing metabolic syndrome (MS). Metformin (MET), an insulin sensitizer drug, is effective in regressing MS and has been recently studied as an adjuvant agent for managing sleep disorders. The present study aimed to assess whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruno, Eleonora, Mulè, Antonino, Galasso, Letizia, Castelli, Lucia, Baldassari, Ivan, Oliverio, Andreina, Venturelli, Elisabetta, Berrino, Franco, Montaruli, Angela, Roveda, Eliana, Pasanisi, Patrizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565813/
https://www.ncbi.nlm.nih.gov/pubmed/37829735
http://dx.doi.org/10.3389/fnut.2023.1240762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565813/
https://www.ncbi.nlm.nih.gov/pubmed/37829735
http://dx.doi.org/10.3389/fnut.2023.1240762

Ejemplares similares